Welcome to the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. As one of the largest academic urology departments in New York City, spread across The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai West, Mount Sinai Morningside, Mount Sinai Brooklyn, and Mount Sinai Queens, we are a leader in our breadth of services, surgical skill, depth of clinical experience, outstanding outcomes, innovative programs of research and discovery, and training opportunities.
We are leaders in robotic surgery for both adults and children, and have one of the busiest programs in the country with 10 robotic surgeons on the Icahn School of Medicine faculty. Our comprehensive prostate cancer program is headed by world leaders in active surveillance, focal therapy, targeted MRI guided biopsy, radiation therapy, robotic and open surgery, pathology, medical oncology, precision medicine, and sexual and urinary rehabilitation. We have one of the largest active surveillance cohorts in the country, and we are committed to differentiating aggressive disease from indolent cancer in order to reduce overtreatment and provide surgery to the right patients at the right time.
Our team oversees numerous clinical trials exploring new diagnostic and treatment alternatives. We have a holistic approach toward healing and have a dedicated team providing alternative medical care, exercise, yoga, and meditation. Our female urology program is focused on urological diseases of women in all stages of life. Our men's health program addresses all health needs for men at one location.
We are dedicated educators and researchers, as well as clinicians with advanced fellowship training in specific sub specialties on the cutting-edge of medical and technological advances in our field. Our department is one of the few in the country with a behavioral health scientist on our faculty who studies the psychosocial impact of cancer on patients and is designing programs to help these patients navigate some of the most challenging aspects of their disease.
We are highly engaged in translational research involving genomics, targeted drug therapies, precision urology, system biology, imaging, outcomes, robotic surgery, and computer-based decision models. We have PhDs, MPHs, MDs and several young investigators in the department who either work on bench research or animal models. We have dedicated programs for medical students, residents, and undergraduates for conducting meaningful research under faculty supervision. Our robotic simulator program offers a summer rotation for residents and welcomes medical students from all over the world. Our residents are among the best and brightest, and we are gratified that many of them pursue prestigious fellowships post residency. We hold a strong belief in the value of education and development: learning from one another and our global peers and, in turn, sharing our skills and insights with them in order to burnish our individual and collective expertise.
I consider it an honor and a privilege to lead the Department of Urology at the Mount Sinai Health System. It is a highly satisfying and rewarding workplace for faculty, staff, and students alike. Such an environment results in better and more compassionate patient care and, as a result, exceptional outcomes, our highest goal.
Ash Tewari, MBBS, MCh, FRCS is Professor and Chairman, Milton and Carroll Petrie Department of Urology. Dr. Tewari is an internationally renowned surgeon who has been honored with awards from the American Urological Association, American Society of Clinical Oncology, and European Association of Urology among numerous other professional organizations.